U.S. Retail Distributors Stock News

Wondering whether CRISPR Therapeutics at around US$51.76 is offering fair value or a potential mispricing opportunity? This article breaks down the numbers for you in plain terms. The stock has seen a 6.0% gain over the last week, an 11.9% decline over the past month, and a 3.7% decline year to date, while still showing a 48.4% return over the last year and 19.1% over three years, alongside a 58.0% decline over five years. Recent attention on CRISPR Therapeutics has focused on its position...

Boeing (NYSE:BA) has entered a seven year framework agreement with the U.S. Department of Defense to triple PAC-3 missile seeker production under the Arsenal of Freedom initiative. NASA's Artemis II mission has flown with a Boeing core stage as a central element of the Space Launch System used for the lunar mission. The company has secured additional defense work, including the F-47 next generation stealth fighter contract, expanding its presence in advanced military aviation. For investors...

ATI’s earnings beat puts margins and demand in focus ATI (ATI) recently reported quarterly results that exceeded profit expectations even as revenue stayed roughly flat, putting the spotlight on margins, cost discipline, and the durability of demand for its specialty materials. See our latest analysis for ATI. The latest results arrived alongside a sharp 6.19% 1 day share price return, capping a 31.87% 90 day share price return and a very large 5 year total shareholder return of 607.33%,...

JPMorgan Chase (NYSE:JPM) agreed to pay US$3.25 million to Finra to resolve issues related to broker misconduct and client supervision. The firm is committing US$600,000 in Atlanta to support clean technology initiatives, including a startup build and test facility and related workforce programs. For investors watching large U.S. banks, these developments touch two key areas: regulatory oversight and capital allocation to cleaner technologies. The Finra settlement adds another data point to...

If you are wondering whether Trade Desk's current share price lines up with its underlying value, or if the recent weakness has gone too far, this article breaks down what the numbers are saying. Trade Desk shares last closed at US$20.25, with returns of a 7.9% decline over 7 days, a 29.1% decline over 30 days, a 46.3% decline year to date and a 62.6% decline over 1 year, while the 3 and 5 year returns stand at a 66.3% decline and a 71.7% decline respectively. These moves sit against a...

Why WesBanco (WSBC) Is On Investors’ Radar Without a specific news headline driving attention today, WesBanco (WSBC) is drawing interest as a regional bank. It has US$903.8m in revenue, US$202.6m in net income, and a market value of about US$3.4b. See our latest analysis for WesBanco. At a share price of US$36.13, WesBanco has a 30 day share price return of 8.27% and a year to date share price return of 8.37%, supported by a 1 year total shareholder return of 31.40%. This suggests that...

Flutter Entertainment plc recently continued its large-scale share buyback programme under its up to US$5.00 billion capital return plan, while long-serving independent director Alfred F. Hurley, Jr. confirmed he will retire at the 2026 AGM, after which Nancy Dubuc will become Chair of the Compensation and Human Resources Committee. At the same time, Kenneth Dart has quietly built an economic interest of more than one-fifth of Flutter through total return swaps, raising questions about how...

Maze Therapeutics (MAZE), a clinical stage biopharma focused on kidney and metabolic diseases, has drawn investor attention after recent share price swings and a one-year total return figure that stands in sharp contrast to its recent negative short-term moves. See our latest analysis for Maze Therapeutics. Recent trading has been choppy, with a 1 month share price return showing a 37.66% decline and a year to date share price return showing a 29.37% decline. However, the 1 year total...

Wondering whether Conagra Brands at around US$15.58 is a bargain or a value trap? This article is built to help you make sense of what that price really implies. The stock has seen a 0.4% move over the last week, a 16.5% decline over the last month and a 34.8% decline over the past year, which may have changed how investors think about its risk and potential reward. Recent coverage around Conagra Brands has centered on its position in the packaged food space and how investor sentiment...

Why the Emerald Legacy Advisors move matters for LPL Financial Holdings (LPLA) LPL Financial Holdings (LPLA) is back in focus after announcing that Emerald Legacy Advisors has joined its broker dealer and Registered Investment Advisor platform, bringing about $140 million in client assets from a competing network. The addition highlights how LPLA’s scale, product range, research and technology can appeal to independent advisory practices. This gives investors another concrete data point to...

Why Cleveland-Cliffs Is Back on Investors’ Radar Cleveland-Cliffs (CLF) has been drawing fresh attention after recent share price swings, with the stock up 3.8% over the past week but showing negative returns over the month and past 3 months. See our latest analysis for Cleveland-Cliffs. The recent 9.31% 7 day share price return contrasts with a 26.26% 3 month share price decline and a 33.53% year to date share price fall. The 1 year total shareholder return of 13.71% suggests shorter term...

If you are wondering whether Autodesk at around US$240.65 is starting to look like value or still pricing in a lot of optimism, the valuation picture is more nuanced than a single number on the screen. The stock has returned 1.2% over the last 7 days, following a 7.7% decline over 30 days and a 16.1% decline year to date, while the 1 year return sits at an 8.7% decline and the 3 year return at a 24.6% gain. Recent coverage has focused on Autodesk as a key software name in design and...

Why Ferrari (RACE) is on investors’ radar today Ferrari (RACE) is drawing fresh attention after recent trading left the stock with a year-to-date return of about a 6% decline and a 1-year total return of roughly an 18% decline. See our latest analysis for Ferrari. The recent 5% 1 day share price return to about $351.30 follows a weak 90 day share price return of roughly a 5% decline and a 1 year total shareholder return of about an 18% decline. As a result, recent momentum is tentatively...

Evolv Technologies Holdings (EVLV) has recently drawn attention after its share price closed at US$6.11, with the stock showing a mix of gains over the past month and weaker returns over the past 3 months. See our latest analysis for Evolv Technologies Holdings. Looking beyond the latest move, Evolv Technologies Holdings shows building short term momentum, with a 17.5% 1 month share price return. Its 1 year total shareholder return of 82.93% reflects a much stronger longer term performance...

Why RealReal stock is catching investor attention RealReal (REAL) has drawn fresh interest after recent trading moves left the share price at $10.16, with performance mixed between strong one-year gains and weaker one-month and past three-month returns. See our latest analysis for RealReal. The latest 10.2% one day share price return and 9.5% seven day share price return contrast with weaker 30 day and 90 day share price returns, while the very large three year total shareholder return...

The United States market has shown robust performance, climbing 3.0% in the last week and 26% over the past year, with earnings projected to grow by 16% annually. In such a dynamic environment, identifying small-cap stocks with potential insider action can be a strategic move for investors seeking opportunities that may not yet be fully recognized by the broader market.

The United States market has shown robust growth, rising 3.0% over the last week and climbing 26% in the past year, with expectations of a 16% annual earnings increase in the coming years. In this thriving environment, identifying stocks that are potentially undervalued can present unique opportunities for investors seeking to capitalize on discrepancies between current stock prices and their intrinsic value.

The United States market has shown robust performance, rising 3.0% over the last week and achieving a 26% increase over the past year, with earnings projected to grow by 16% annually. In such a thriving environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business's operations and potential.

The market has climbed 3.0% in the last 7 days and an impressive 26% over the past year, with earnings projected to grow by 16% annually in the coming years. For those looking to invest in smaller or newer companies, penny stocks — despite their somewhat outdated name — can still offer surprising value. These stocks often represent a mix of affordability and growth potential when backed by solid financials, and we will explore several that stand out for their financial strength.

The United States market has shown impressive growth, rising 3.0% over the last week and 26% over the past year, with earnings projected to increase by 16% annually. In this robust environment, identifying promising stocks involves looking for companies that combine potential for strong earnings growth with unique market positions or innovative products.

The United States market has experienced a notable upswing, climbing 3.0% in the last 7 days and 26% over the past year, with earnings forecasted to grow by 16% annually. In this buoyant environment, dividend stocks can be an attractive option for investors seeking steady income and potential appreciation amidst positive market momentum.

In early April 2026, Avantor, Inc. announced that Executive Vice President and Chief Financial Officer R. Brent Jones will leave the company on or before June 24, 2026, with Senior Vice President and Chief Accounting Officer Steve Eck stepping in as interim CFO while a search for a permanent successor is underway. This leadership transition elevates a long-serving internal finance leader with extensive accounting and industrial experience, raising questions about continuity in Avantor's...

If you are wondering whether Firefly Aerospace at US$38.12 is offering good value or stretching expectations, you will want to look past the headline share price and into what the current valuation really reflects. Over shorter periods the stock has been active, with a 28.1% return over the last 7 days, 83.7% over 30 days, and 60.4% year to date, which can change how the market views both its potential and its risks. Recent coverage around Firefly Aerospace has focused on its position within...

ANI Pharmaceuticals, Inc. (NasdaqGM: ANIP) has launched Isosorbide Mononitrate Tablets following final FDA approval. The product adds a new limited competition generic to the company’s portfolio of prescription pharmaceuticals. This launch expands ANI Pharmaceuticals' presence in generic cardiovascular treatments and broadens its revenue base. For you as an investor, the key point is that ANI Pharmaceuticals focuses on niche and limited competition generics, alongside specialty branded...